FKBP51 disrupts the insulin signaling pathway and impairs mitochondrial bioenergetics in HepG2 cells
Abstract FKBP51 reportedly antagonizes insulin signaling by reducing Akt activity, thus contributing to insulin resistance and weight gain. This has been well established in FKBP51 knock-out mice. However, the effects of FKBP51 overexpression and its associated mechanisms have not been explored in l...
שמור ב:
| Principais autores: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Portfolio
2026-02-01
|
| סדרה: | Scientific Reports |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1038/s41598-026-40414-9 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
